Document Detail


Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.
MedLine Citation:
PMID:  19082486     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Doxorubicin is an important component of combination therapy for muscle-invasive urinary bladder cancer. Treatment with this topoisomerase II poison is able to interfere with cell cycle progression and lead to cancer cell death. Using FACS analysis, Western immunoblotting and semi-quantitative RT-PCR, we studied the effects of doxorubicin on cell cycle progression and apoptosis, and also explored the possibility of using groups of genes as biomarkers of prognosis and/or response to doxorubicin treatment in human urinary bladder cancer cells. Doxorubicin induced dose-dependent G2/M and/or G1/S cell cycle arrest, followed by grade- and dose-dependent reduction in the amount of the cytosolic trimeric form of FasL, activation of Caspase-8, Caspase-9, Caspase-3, cleavage of PARP, Lamin A/C, Bcl-XL/S and interestingly Hsp90, and finally cell death. Data presented here also suggest the use of the expression patterns of Cyclin-E2, Cyclin-F, p63, p73, FasL, TRAIL, Tweak, Tweak-R, XAF-1, OPG and Bok genes for identification of the differentiation grade, and Cyclin-B2, GADD45A, p73, FasL, Bik, Bim, TRAIL, Fas, Tweak-R, XAF-1, Bcl-2, Survivin, OPG, DcR2 and Bcl-XL genes for the detection of response to doxorubicin in human bladder cancer cells.
Authors:
Dimitrios J Stravopodis; Panagiotis K Karkoulis; Eumorphia G Konstantakou; Sophia Melachroinou; Antonis D Lampidonis; Dimitra Anastasiou; Stefanos Kachrilas; Niki Messini-Nikolaki; Issidora S Papassideri; Gerasimos Aravantinos; Lukas H Margaritis; Gerassimos E Voutsinas
Related Documents :
7977636 - Small cell carcinomas of the lung express the bcl-2 protein.
11930666 - Overexpression of bcl-2 protects hepatoma cell line hcc-9204 from ethanol-induced apopt...
16724266 - C-myc downregulation: a critical molecular event in resveratrol-induced cell cycle arre...
18767026 - Non-peptidic small molecule inhibitors against bcl-2 for cancer therapy.
16150566 - Estiv questionnaire on the acquisition and use of primary human cells and tissue in tox...
8820426 - Cyp3a-like cytochrome p450-mediated metabolism and polarized efflux of cyclosporin a in...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of oncology     Volume:  34     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-16     Completed Date:  2009-02-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  137-60     Citation Subset:  IM    
Affiliation:
Department of Cell Biology and Biophysics, Faculty of Biology, University of Athens, Panepistimiopolis, Zografou, 15784 Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibiotics, Antineoplastic / pharmacology*
Apoptosis / drug effects*
Blotting, Western
Carcinoma, Transitional Cell / metabolism,  pathology*
Cell Cycle / drug effects*
Cell Cycle Proteins / metabolism
Cell Differentiation / drug effects
Cell Line, Tumor
Cell Proliferation / drug effects
Doxorubicin / pharmacology*
Flow Cytometry
Gene Expression Profiling
Humans
Immunoblotting
Neoplasm Staging
Oligonucleotide Array Sequence Analysis
RNA, Messenger / genetics,  metabolism
Reverse Transcriptase Polymerase Chain Reaction
Tumor Markers, Biological
Urinary Bladder Neoplasms / metabolism,  pathology*
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/Cell Cycle Proteins; 0/RNA, Messenger; 0/Tumor Markers, Biological; 23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.
Next Document:  Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras trans...